Field clinical study evaluating the efficacy and safety of an oral formulation containing milbemycin oxime/praziquantel (Milbemax®, Novartis Animal Health) in the chemoprevention of the zoonotic canine infection by Dirofilaria repens. (Q34022217)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Field clinical study evaluating the efficacy and safety of an oral formulation containing milbemycin oxime/praziquantel (Milbemax®, Novartis Animal Health) in the chemoprevention of the zoonotic canine infection by Dirofilaria repens. |
scientific article |
Statements
Field clinical study evaluating the efficacy and safety of an oral formulation containing milbemycin oxime/praziquantel (Milbemax®, Novartis Animal Health) in the chemoprevention of the zoonotic canine infection by Dirofilaria repens (English)
Angela Di Cesare
Gabriele Braun
Emanuela Di Giulio
Vincenzo Aquilino
Roberto Bartolini
Francesco La Torre
Silvana Meloni
Jason Drake
Federico Pandolfi
Stefania Avolio
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference